Our recent studies confirmed that the HBV RNAs present in the serum of chronic hepatitis B( CHB) patients are pregenomic RNAs( pgRNAs) with a size of 3. 5 kb. These pgRNAs are located in virus- like particles whose morphological structure is similar to that of Dan granules. Since pgRNAs can only be transcribed from the covalently closed circular DNA( ccc DNA) in virus located in the nuclear of infected hepatocytes,and the production of pgRNAs is not affected by nucleos( t) ide analogues( NAs),the presence of viral RNA in serum can reflect the presence of ccc DNA in hepatocytes and its transcriptional activity in patients treated with medication. It can be inferred that serum viral RNA can be used as a potential index for safe withdrawal of NAs. Our results based on a small- sample cohort show that the presence of HBV RNA in serum at the time of withdrawal is indeed associated with virological rebound after drug withdrawal.
[1]KOCK J,THEILMANN L,GALLE P,et al.Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus[J].Hepatology,1996,23(3):405-413.
|
[2]JANSEN L,KOOTSTRA NA,van DORT KA,et al.Hepatitis B virus pregenomic RNA is present in virions in plasma and is associated with a response to pegylated interferon alfa-2a and nucleos(t)ide analogues[J].J Infect Dis,2016,213(2):224-232.
|
[3]TSUGE M,MURAKAMI E,IMAMURA M,et al.Serum HBV RNA and HBe Ag are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients[J].J Gastroenterol,2013,48(10):1188-1204.
|
[4]van BOMMEL F,BARTENS A,MYSICKOVA A,et al.Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors[J].Hepatology,2015,61(1):66-76.
|
[5]WANG J,SHEN T,HUANG XB,et al.Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound[J].J Hepatol,2016.[Epub ahead of print]
|
[6]SUNG WK,ZHENG H,LI S,et al.Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma[J].Nat Genet,2012,44(7):765-769.
|
[7]JIANG S,YANG Z,LI W,et al.Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis[J].PLo S One,2012,7(9):e40363.
|
[8]LI X,ZHANG J,YANG Z,et al.The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma[J].J Hepatol,2014,60(5):975-984.
|
[9]SHOUVAL D,RAGER-ZISMAN B,QUAN P,et al.Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus[J].J Clin Invest,1983,72(2):707-717.
|
[10]SHOUVAL D,REID LM,CHAKRABORTY PR,et al.Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA[J].Cancer Res,1981,41(4):1342-1350.
|